A number of other equities research analysts have also recently weighed in on XRAY. Bank of America assumed coverage on shares of DENTSPLY SIRONA in a report on Monday, March 18th. They issued a buy rating and a $57.00 price objective on the stock. William Blair restated an outperform rating on shares of eXp World in a report on Monday, March 18th. Barrington Research cut their price objective on shares of CBS from $72.00 to $60.00 and set an outperform rating on the stock in a report on Monday, May 6th. UBS Group dropped their target price on shares of MEG Energy from C$8.70 to C$6.00 in a research note on Tuesday, March 12th. Finally, Zacks Investment Research upgraded shares of GALP ENERGIA SG/ADR from a sell rating to a hold rating in a research note on Monday, May 27th. Eight analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The stock currently has a consensus rating of Buy and a consensus price target of $53.77.
Shares of NASDAQ XRAY opened at $56.93 on Friday. The stock has a market capitalization of $13.32 billion, a PE ratio of 27.77, a P/E/G ratio of 2.12 and a beta of 0.98. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.06 and a quick ratio of 1.35. DENTSPLY SIRONA has a 1 year low of $33.93 and a 1 year high of $59.40. The company’s 50-day moving average is $56.51.
DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Friday, May 3rd. The medical instruments supplier reported $0.49 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.39 by $0.10. The business had revenue of $946.20 million for the quarter, compared to analysts’ expectations of $925.13 million. DENTSPLY SIRONA had a negative net margin of 26.48% and a positive return on equity of 8.99%. The business’s revenue was down 1.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.45 earnings per share. On average, equities analysts anticipate that DENTSPLY SIRONA will post 2.35 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, July 12th. Investors of record on Friday, June 28th were given a dividend of $0.0875 per share. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. The ex-dividend date of this dividend was Thursday, June 27th. This represents a $0.35 dividend on an annualized basis and a yield of 0.61%. DENTSPLY SIRONA’s dividend payout ratio is 17.41%.
In related news, CEO Donald M. Jr. Casey acquired 10,000 shares of the stock in a transaction that occurred on Wednesday, May 29th. The shares were bought at an average price of $53.68 per share, for a total transaction of $536,800.00. Following the completion of the transaction, the chief executive officer now directly owns 105,631 shares in the company, valued at $5,670,272.08. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Daniel P. Key acquired 3,697 shares of the stock in a transaction that occurred on Tuesday, May 7th. The shares were bought at an average price of $54.68 per share, for a total transaction of $202,151.96. Following the transaction, the senior vice president now owns 9,024 shares of the company’s stock, valued at $493,432.32. The disclosure for this purchase can be found here. In the last 90 days, insiders have purchased 26,417 shares of company stock worth $1,425,395 and have sold 138,922 shares worth $7,631,805. 0.62% of the stock is owned by corporate insiders.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Veritas Asset Management LLP raised its position in DENTSPLY SIRONA by 0.6% in the first quarter. Veritas Asset Management LLP now owns 13,549,320 shares of the medical instruments supplier’s stock worth $671,911,000 after acquiring an additional 76,545 shares during the period. Geode Capital Management LLC raised its position in DENTSPLY SIRONA by 6.6% in the fourth quarter. Geode Capital Management LLC now owns 2,997,698 shares of the medical instruments supplier’s stock worth $111,355,000 after acquiring an additional 185,780 shares during the period. Champlain Investment Partners LLC raised its position in DENTSPLY SIRONA by 2.9% in the first quarter. Champlain Investment Partners LLC now owns 2,890,795 shares of the medical instruments supplier’s stock worth $143,355,000 after acquiring an additional 80,555 shares during the period. Northern Trust Corp raised its position in DENTSPLY SIRONA by 0.8% in the first quarter. Northern Trust Corp now owns 2,602,651 shares of the medical instruments supplier’s stock worth $129,065,000 after acquiring an additional 21,321 shares during the period. Finally, DNB Asset Management AS raised its position in DENTSPLY SIRONA by 6.5% in the first quarter. DNB Asset Management AS now owns 2,050,276 shares of the medical instruments supplier’s stock worth $101,673,000 after acquiring an additional 125,716 shares during the period. Institutional investors and hedge funds own 91.66% of the company’s stock.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Recommended Story: Do back-end load funds outperform no-load funds?
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.